Print preview Close

Showing 7 results

Archival description
Vaccine and Infectious Disease Organization (VIDO)
Print preview View:

5 results with digital objects Show results with digital objects

C.H. Bigland fonds

  • MG 89
  • Fonds
  • 1964-1983

This fonds contains correspondence, minutes, reports, newsletters, reprints and notes pertaining to the activities and interests of C.H. Bigland during his tenure as Professor of Veterinary Microbiology and Director of the Veterinary Infectious Diseases Organization (VIDO).

Bigland, Christopher Hedley

Dr. Chris Bigland - Portrait

Head and shoulders image of Dr. Chris Bigland, Professor and Head of Veterinary Microbiology and founding Director of VIDO.

Bio/Historical Note: Dr. Christopher Hedley Bigland was born in Calgary on 15 October 1919. He received his DVM from the University of Toronto in 1941. This was followed by a Doctor of Veterinary Public Health from the University of Toronto in 1946 and an MSc in physiology from the University of Alberta in 1960. Dr. Bigland became a member of the faculty of the University of Saskatchewan in 1964 with his appointment as Professor and Head of the Department of Veterinary Microbiology. In 1974 Dr. Bigland became the first Director of the Vaccine and Infectious Disease Organization (VIDO) and remained in that post until his retirement in 1984. Dr. Bigland died in Saskatoon in 2005 at age 86.

N.O. Nielsen fonds

  • MG 80
  • Fonds
  • 1959-1984 [inclusive]; 1963-1983 [predominant].

This fonds contains a number of files concerning the Western College of Veterinary Medicine (WCVM), including the activities and research projects of the Veterinary Infectious Diseases Organization (VIDO), the 1976 Study of Veterinary Manpower in Canada, computer assisted Animal Health Management, and the Preventive Medicine Committee: the latter two specifically concerning the establishment of a herd health data laboratory and disease control programs. In addition, there are several files related to Professor Nielsen's involvement with the Institute for Northern Studies (INS), the President's Advisory Council on Programs for People of Native Ancestry, game ranching in the north, and the Arctic Training Centre at Rankin Inlet. There is a considerable amount of material concerning the Environmental Advisory Council, and specifically, the Churchill River inquiry, Key Lake, the Environment 80 Report, and an uranium pollution control policy. It also contains some material concerning the establishment of a zoo at the Saskatoon Forestry Farm

Nielsen, Niels Ole, 1930- (Professor of Veterinary Pathology)

Veterinary Infectious Disease Organization - Ceremony

R.W. Begg, University President, speaking from podium during an outdoor ceremony marking the opening of the Veterinary Infectious Disease Organization lab. Attendees seated behind Begg are Dr. Niels O. Nielson, dean, Western College of Veterinary Medicine; W. Weir, E. Kaeding, Dr. Chris Bigland, director of VIDO; and George Shepherd.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

Veterinary Infectious Disease Organization - Official Opening

R.W. Begg, University President, speaks from podium during the opening of the Vaccine and Infectious Disease Organization (VIDO). Dignitaries seated are (l to r): M. Moore; Herman Rolfes, Saskatchewan Minister of Continuing Education; and Dr. Chris Bigland, director of VIDO.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

Veterinary Infectious Disease Organization - Tour

Touring the Vaccine and Infectious Disease Organization (VIDO) facilities are (l to r): R.W. Begg, University President; Dr. Christopher H. Bigland, director of VIDO; and Allan Blakeney, Premier of Saskatchewan.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.